Metastatic Breast Cancer in Austria

Launched by ARBEITSGEMEINSCHAFT MEDIKAMENTOESE TUMORTHERAPIE · Mar 8, 2019

Keywords

ClinConnect Summary

This clinical trial is focused on understanding metastatic breast cancer, which is when breast cancer spreads to other parts of the body. In Austria, many women are diagnosed with breast cancer each year, and some of these cases already show signs of spreading when they are first found. This trial is creating a comprehensive registry, which is a detailed collection of information about patients with metastatic breast cancer throughout Austria. The goal is to gather important data about how common this condition is and how it is treated.

To be eligible for this study, participants need to have a confirmed diagnosis of breast cancer, along with evidence that it has spread within the last 10 years. Importantly, anyone can join the study, regardless of gender, as long as they meet these criteria and agree to take part in the registry. Participants can expect their medical histories, tumor details, and treatment plans to be recorded anonymously, helping researchers learn more about this serious condition and improve care for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Histological evidence of breast cancer
• • Histological and/or radiological evidence of metastases
• • Metastasis within 10 years of registry initiation
• • Signed informed consent (if a patient has already died at the time of entry, the entry can be made without a declaration of consent)
• Exclusion Criteria:
• • Due to the non-interventional design of the registry there are no specific exclusion criteria.